May 14, 2026 05:00PM
May 13, 2026 05:00PM
May 6, 2026 05:00PM
Mar 12, 2026 05:00PM
Mar 10, 2026 09:00AM
Feb 25, 2026 09:30AM
Jan 15, 2026 09:00AM Precipio Takes Major Steps Toward a Clean Balance Sheet
Dec 5, 2025 10:00AM
Nov 14, 2025 04:30PM
Nov 4, 2025 05:00PM
Sep 2, 2025 10:01AM
Sep 2, 2025 10:00AM
Aug 13, 2025 05:00PM
Jul 31, 2025 04:30PM Precipio Announces Q2-2025 Shareholder Update Call
Jul 11, 2025 04:30PM
Jul 11, 2025 04:30PM
Jun 16, 2025 12:00PM
May 14, 2025 05:00PM
May 1, 2025 05:00PM
Mar 17, 2025 05:00PM
Feb 25, 2025 09:30AM Precipio Achieves Key Q4-2024 Financial Goals: Positive Adjusted EBITDA and Positive Cash Flow (unaudited)
Jan 16, 2025 05:00PM
Nov 6, 2024 05:00PM
Oct 8, 2024 10:00AM
Sep 6, 2024 04:00PM
Aug 15, 2024 05:00PM
Jul 25, 2024 09:00AM
Jul 17, 2024 09:00AM Precipio Reports $4.4M for Q2-2024 (unaudited) Revenues, a leap of 30% from Q1-2024
Jun 13, 2024 04:00PM
Jun 12, 2024 04:00PM
Jun 12, 2024 04:00PM
Jun 12, 2024 09:04AM
Jun 12, 2024 09:00AM
May 6, 2024 05:00PM
Mar 25, 2024 05:00PM Precipio Announces Year end 2023 Shareholder Update Call
Feb 13, 2024 10:00AM
Feb 6, 2024 10:01AM
Feb 6, 2024 10:00AM
Jan 23, 2024 10:00AM
Jan 17, 2024 10:30AM
Jan 2, 2024 09:02AM
Jan 2, 2024 09:00AM Precipio Announces Christina Valauri joins the Board of Directors
Nov 16, 2023 05:00PM
Oct 18, 2023 09:00AM
Oct 3, 2023 10:00AM
Sep 28, 2023 09:00AM
Sep 25, 2023 11:00AM
Sep 25, 2023 11:00AM
Sep 13, 2023 09:30AM Precipio's (PRPO) Pathology Division Exceeds Breakeven Revenues in August, Four Months Ahead of Plan
Sep 13, 2023 09:30AM

1,197,259 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All